Published online Sep 9, 2026. doi: 10.5409/wjcp.118413
Revised: February 21, 2026
Accepted: April 8, 2026
Published online: September 9, 2026
Processing time: 212 Days and 9 Hours
Central line-associated bloodstream infections (CLABSI) are a major cause of mor
To evaluate the impact of a multimodal QI initiative on reducing CLABSI inci
This prospective interventional study was conducted in a level-3 teaching NICU in Western India. All neonates with central venous access during NICU stay were included. Baseline CLABSI rates were measured over a pre-intervention period. The intervention bundle comprised strengthening hand hygiene practices, custo
The baseline CLABSI rate was 6.4 per 1000 central line days, which decreased to 1.1 per 1000 central line days post-intervention; an 83% reduction. During the 18-month sustainability phase, rates remained low at 0.96 per 1000 central line days. Hand hygiene compliance, adherence to central line bundles, and nursing education coverage improved significantly throughout the intervention and maintenance phases.
Implementation of a structured, multimodal QI bundle emphasizing hand hygiene, tailored central line care bun
Core Tip: A structured, multimodal quality improvement initiative led to a substantial and sustained reduction in neonatal central line associated blood stream infection rates in a level-3 neonatal intensive care unit. By strengthening hand hygiene, customizing central line care bundles, reinforcing environmental cleaning, conducting regular audits, and providing ongoing nursing education through iterative Plan-Do-Study-Act cycles, central line associated blood stream infection rates fell by over 80% and remained low for 18 months. This low-cost, pragmatic approach is feasible and reproducible in resource-constrained neonatal intensive care unit settings, including low- and middle-income countries.
- Citation: Pillai A, Kabra N, Nayak A, Bhanushali M, Balasubramanian H, Shivananda S. Transforming central line associated blood stream infection prevention in neonates: Results from a multimodal quality improvement initiative. World J Clin Pediatr 2026; 15(3): 118413
- URL: https://www.wjgnet.com/2219-2808/full/v15/i3/118413.htm
- DOI: https://dx.doi.org/10.5409/wjcp.118413
Neonatal sepsis remains a leading cause of morbidity and mortality worldwide, particularly in low- and middle-income countries (LMICs), where access to advanced neonatal care is often limited. Sepsis accounts for a substantial proportion of neonatal intensive care unit (NICU) admissions, leading to prolonged hospitalization, increased antibiotic exposure, and elevated healthcare costs[1,2]. According to the Global Burden of Disease database, neonatal sepsis was the third most common cause of neonatal mortality globally, responsible for an estimated 336300 deaths annually[3,4]. Beyond its imme
Critically ill and premature neonates frequently require prolonged central venous access for administration of intra
The clinical and economic impact of CLABSI is considerable. Each episode is associated with increased morbidity and mortality, prolonged NICU stay, and substantial additional treatment costs[12,13]. Management typically requires ex
Baseline surveillance in our level III NICU between October 2019 and March 2020 demonstrated a CLABSI rate of 6.4 per 1000 central line days, highlighting a significant opportunity for improvement. Recognizing that the majority of CLABSIs are preventable, our team initiated a structured QI project aimed at reducing CLABSI incidence by 50% within 12 months. The intervention focused on implementing evidence-based central line care bundles, strengthening infection prevention and control practices, and enhancing nursing competence through structured education, standardized protocols, and continuous audit-feedback mechanisms. In addition to achieving initial reduction, the project aimed to sustain improvements over an additional 18-month period to ensure durable impact on patient safety and clinical outcomes. Through this initiative, we sought not only to lower CLABSI rates but also to foster a culture of safety, accountability, and continuous learning within the NICU team. This manuscript describes the design, implementation, and outcomes of this QI project, contributing to the growing evidence that systematic, multidisciplinary efforts can meaning
This prospective QI initiative was conducted in the Level III NICU in Mumbai, serving both inborn and outborn neonates from Maharashtra and neighboring states. The NICU admits approximately 1000 neonates annually and comprises 25 level III beds, 35 level II beds, and 45 Kangaroo Mother Care beds. The multidisciplinary team includes three full-time consultant neonatologists, 60 trained staff nurses, and 14 fellows/residents. Nurse-to-patient ratios are maintained at 1:2 for level III and 1:3 for level II care, in accordance with national and international standards.
All neonates admitted to the NICU between April 2020 and March 2021 who required central venous access via umbilical venous catheter, peripherally inserted central catheter, or surgically placed central line, at any time during their NICU stay were eligible for inclusion. Central line days represented the total number of days that the neonate had one or more central lines in place during the surveillance period. Neonates with a documented bloodstream infection prior to line insertion were excluded to avoid misattribution of infection source.
A multidisciplinary QI team was constituted, including neonatologists, infection control nurses, NICU staff nurses, fellows, and housekeeping personnel. The team conducted a root cause analysis to identify modifiable factors contri
Findings from the analysis informed the development of a key driver diagram following the Institute for Healthcare Improvement methodology. The key driver diagram delineated the overall project aim - reducing CLABSI rates in the NICU - along with primary drivers (such as adherence to insertion and maintenance bundles, strict aseptic technique, and staff education), secondary drivers, and specific change ideas (Figure 1). This framework served as the operational blue
The QI initiative was implemented over a 12-month period and divided into three iterative phases. Each phase incorpo
During the initial phase, existing central line insertion and maintenance protocols were reviewed and revised in accor
The second phase focused on strengthening compliance with aseptic practices through targeted education and structured audits. Hand hygiene monitoring was intensified, with infection control nurses conducting regular audits. Structured educational modules were developed for nursing staff, covering topics such as neonatal sepsis, CLABSI prevention, aseptic technique, and adherence to bundle components. Training workshops and demonstration sessions were orga
In the final phase, full implementation of the central line insertion and maintenance bundles was undertaken across the NICU. Bedside “central line alert cards” were introduced to prompt daily assessment of line necessity and adherence to best practices for line access and maintenance (Supplementary Figure 3). Regular audit and feedback sessions were con
Following the 12-month implementation period, a sustainability phase was conducted from April 2021 to September 2022 to ensure long-term adherence to best practices and consolidation of gains achieved during the intervention period. This phase emphasized continuous learning, reinforcement of standardized protocols, and institutionalization of safe line-care practices through three key strategies.
Simulation-based training: Periodic simulation and role-play sessions were introduced to strengthen procedural compe
Reflective learning: Structured case-based debrief sessions were conducted following each CLABSI episode. These sessions allowed multidisciplinary teams to review event timelines, identify contributing factors, and discuss targeted preventive strategies. The reflective learning format encouraged self-assessment, accountability, and reinforcement of a safety-oriented culture within the unit.
Periodic re-audits and feedback: Compliance with hand hygiene and central line bundle components was monitored through twice-monthly audits conducted by infection control personnel. Findings were shared in real time with the entire care team through feedback meetings and visual dashboards, ensuring transparency and collective ownership of outcomes. The regular audit-feedback cycle supported early detection of deviations and maintained high standards of practice over time. The study timeline and phases are described in Figure 2.
The primary outcome was the CLABSI rate, expressed as the number of CLABSI episodes per 1000 central line days, and compared with baseline data collected between October 2019 and March 2020. CLABSI was defined according to the Centers for Disease Control and Prevention/National Healthcare Safety Network (CDC/NHSN) criteria, ensuring standardization and comparability with international benchmarks. To evaluate fidelity of implementation and monitor adherence to infection prevention practices, the process measures included hand hygiene compliance, compliance to insertion/maintenance bundle and staff education coverage.
Prospective data were collected by trained members of the QI team throughout the intervention and sustainability phases. Process audits were performed three times per week using a standardized observation tool developed in align
Monthly QI team meetings were convened to review audit findings, identify gaps, and plan corrective actions. Ana
The study was approved by the Institutional Ethics Committee of Surya Children’s Hospital, approval No. EC-05/12/2020. A waiver of informed consent was granted as the project constituted a minimal-risk QI initiative, did not involve deviation from standard care practices, and aimed to enhance patient safety. Access to identifiable information was res
During the 12-month implementation period (April 2020-March 2021), 683 neonates were admitted to the level III NICU, including 77 extremely low birth weight infants. A total of 1816 central line days were recorded. In comparison, the pre-intervention surveillance period (October 2019-March 2020) included 457 admissions and 1249 central line days. The proportion of extremely low birth weight infants and total catheter days was comparable between the study periods, minimizing potential confounding due to case-mix variation (Table 1).
| Characteristics | Pre-intervention period (6 months) | Implementation period (12 months) | Sustainability period (18 months) |
| Total number of admissions | 457 | 683 | 1218 |
| No. of ELBW | 46 (10) | 77 (11.2) | 160 (13.1) |
| Central line days | 1249 | 1816 | 4145 |
| No. of CLABSI cases | 8 | 2 | 4 |
| CLABSI rates/1000 central line days | 6.4 | 1.1 | 0.96 |
| Compliance to hand hygiene (%) | 97.9% | 98.1% | 97.7% |
| Compliance to insertion bundle (%) | - | 100% | 97% |
| Compliance to maintenance bundle checklist (%) | - | Nurses 86% | Nurses 94% |
| Doctors 82% | Doctors 93% | ||
| Compliance to nurses education (% staff coverage) | - | 62% | 81% |
Baseline CLABSI incidence was 6.4 per 1000 central line days, corresponding to eight confirmed episodes during the pre-intervention period. Following implementation of the multimodal QI bundle, the rate declined to 1.1 per 1000 central line days; with only two CLABSI episodes reported during the intervention period. Statistical process control charts demon
Baseline hand hygiene compliance was high (97.9%), and remained consistently above 97% throughout the intervention and sustainability phases. The lowest adherence (88%) was observed for the “after contact with patient surroundings” moment, which improved following targeted reminders and reinforcement through ongoing education. Following im
This project demonstrated a sustained and clinically meaningful reduction in CLABSI within a busy, level 3 NICU in a LMIC. By implementing a pragmatic, multimodal bundle, the CLABSI rates reduced by 83% in the unit. The incidence of CLABSI may be influenced by multiple factors including gestational age, birth weight, severity of illness, nurse-to-patient ratio, and total number of catheter days[7]. In our study population, these baseline demographics remained similar during all the study phases. These findings underscore the power of a systems-based approach that combines evidence-based technical interventions with behavioural and cultural change strategies.
The findings of this QI initiative are consistent with previously published studies demonstrating the effectiveness of bundled interventions in reducing CLABSIs in NICUs[12,16,17,19,20]. Fisher et al[21] reported a 71% reduction in CLABSI rates, following a QI project conducted over 13 NICUs in North Carolina by performing monthly webinars and learning sessions regarding unique CLABSI bundle elements. They reported a reduction in CLABSI rates from 3.94 to 1.16 per 1000 line days following implementation of the care bundle[21]. Likewise, Balla et al[19] documented an 89% reduction in CLABSI, although the unit had a very high baseline CLABSI incidence of 31.7 per 1000 line days. The baseline CLABSI rate in our unit (6.4 per 1000 line days) was comparable to rates reported by the INICC for middle-income countries, where infection burdens are often significantly higher than those reported in high-income settings[22]. These results demonstrate that high-quality infection prevention outcomes are attainable even in resource-constrained environments when a structured, multidisciplinary, and data-driven approach is employed.
Despite the successful implementation and sustained reduction in CLABSI rates, several operational and contextual challenges were encountered during the course of the QI initiative. The multidisciplinary team proactively identified these barriers and employed context-specific mitigation strategies to ensure uninterrupted progress and long-term sus
| Challenge | Description | Mitigation strategy |
| Variable adherence to maintenance bundle during initial phases | Early audits revealed inconsistent compliance with maintenance checklists, particularly during night shifts and high-workload periods | Real-time feedback during bedside rounds, peer mentoring, and reinforcement of accountability through shared nurse-physician responsibility for checklist completion improved compliance to > 90% by phase 3 |
| High staff turnover and rotational postings | Frequent rotation of fellows and nursing staff led to variability in familiarity with protocols and compromised consistency in central line care practices | A structured orientation and modular training program was institutionalized for all new staff, supplemented by quarterly simulation-based refresher sessions to reinforce core competencies |
| Competing clinical priorities during the COVID-19 pandemic | Redeployment of personnel, heightened infection control demands, and restricted group gatherings challenged consistent implementation and training schedules | Smaller, repeated training sessions adhering to infection control norms were conducted using audiovisual aids and virtual platforms. Dedicated infection control nurses ensured continuity of audit and feedback processes |
| Resistance to change and behavioral inertia | Initial reluctance among some staff members to adopt revised aseptic protocols and documentation requirements hindered early compliance | Continuous engagement through inclusive team meetings, sharing of infection data trends, and recognition of high-performing individuals fostered ownership and motivation. Behavioral reinforcement through feedback overcome resistance |
| Documentation fatigue and checklist overload | The introduction of multiple checklists and audit tools increased perceived workload among nurses and fellows | Redundant forms were consolidated, and electronic data entry via a simplified digital dashboard was introduced to streamline documentation and facilitate real-time data visualization |
| Environmental hygiene and equipment cleaning gaps | Inconsistent disinfection of high-touch equipment (syringe pumps, infusion stands) contributed to occasional breaches in asepsis | Daily cleaning schedules and visual reminder posters were implemented. Infection control nurses conducted unannounced spot checks, and cleaning logs were reviewed weekly in QI meetings |
| Maintaining sustainability beyond the active intervention phase | Post-implementation, the risk of gradual decline in compliance and attention to line care was recognized | Sustainability was ensured through periodic re-audits, case-based debrief sessions after any CLABSI event, and integration of bundle adherence metrics into the unit’s routine performance dashboard |
Staff education program used a combination of didactic instruction, simulation-based practice, and case-based reflec
This QI initiative demonstrated methodological and implementation strengths that enhance its credibility and replicability. The prospective design, systematic data collection, and use of iterative Plan-Do-Study-Act cycles enabled conti
This QI initiative achieved a sustained 83% reduction in CLABSI rates in a high-volume, resource-limited NICU. The success of the intervention stemmed from an integrated, evidence-based bundle encompassing standardized clinical protocols, bedside prompts, continuous audit and feedback, and structured nurse education. These findings demonstrate that meaningful and durable reductions in healthcare-associated infections are achievable in resource-constrained settings through a systems-oriented, multidisciplinary approach. Sustained impact will require ongoing surveillance, periodic staff retraining, and strong institutional commitment to infection prevention.
The authors sincerely acknowledge the efforts of the neonatal intensive care unit team, including nurses, resident doctors, consultants, and housekeeping staff, whose commitment to infection prevention practices made this quality improvement initiative successful.
| 1. | Dramowski A, Bolton L, Fitzgerald F, Bekker A; NeoNET AFRICA Partnership. Neonatal Sepsis in Low- and Middle-income Countries: Where Are We Now? Pediatr Infect Dis J. 2025;44:e207-e210. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 21] [Reference Citation Analysis (0)] |
| 2. | Milton R, Gillespie D, Dyer C, Taiyari K, Carvalho MJ, Thomson K, Sands K, Portal EAR, Hood K, Ferreira A, Hender T, Kirby N, Mathias J, Nieto M, Watkins WJ, Bekele D, Abayneh M, Solomon S, Basu S, Nandy RK, Saha B, Iregbu K, Modibbo FZ, Uwaezuoke S, Zahra R, Shirazi H, Najeeb SU, Mazarati JB, Rucogoza A, Gaju L, Mehtar S, Bulabula ANH, Whitelaw AC, Walsh TR; BARNARDS Group, Chan GJ. Neonatal sepsis and mortality in low-income and middle-income countries from a facility-based birth cohort: an international multisite prospective observational study. Lancet Glob Health. 2022;10:e661-e672. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 182] [Cited by in RCA: 146] [Article Influence: 36.5] [Reference Citation Analysis (0)] |
| 3. | GBD 2015 Child Mortality Collaborators. Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015. Lancet. 2016;388:1725-1774. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 541] [Cited by in RCA: 554] [Article Influence: 55.4] [Reference Citation Analysis (0)] |
| 4. | Mu C, Liu F, Tian T, Feng M, Dang X, Xie L, Liu J, Li X. Analysis of the global burden and key risk factors of neonatal sepsis and other neonatal infections in 204 countries and territories, 1990-2021. Front Med (Lausanne). 2025;12:1536948. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 5] [Reference Citation Analysis (0)] |
| 5. | Wang H, Liddell CA, Coates MM, Mooney MD, Levitz CE, Schumacher AE, Apfel H, Iannarone M, Phillips B, Lofgren KT, Sandar L, Dorrington RE, Rakovac I, Jacobs TA, Liang X, Zhou M, Zhu J, Yang G, Wang Y, Liu S, Li Y, Ozgoren AA, Abera SF, Abubakar I, Achoki T, Adelekan A, Ademi Z, Alemu ZA, Allen PJ, AlMazroa MA, Alvarez E, Amankwaa AA, Amare AT, Ammar W, Anwari P, Cunningham SA, Asad MM, Assadi R, Banerjee A, Basu S, Bedi N, Bekele T, Bell ML, Bhutta Z, Blore JD, Basara BB, Boufous S, Breitborde N, Bruce NG, Bui LN, Carapetis JR, Cárdenas R, Carpenter DO, Caso V, Castro RE, Catalá-Lopéz F, Cavlin A, Che X, Chiang PP, Chowdhury R, Christophi CA, Chuang TW, Cirillo M, da Costa Leite I, Courville KJ, Dandona L, Dandona R, Davis A, Dayama A, Deribe K, Dharmaratne SD, Dherani MK, Dilmen U, Ding EL, Edmond KM, Ermakov SP, Farzadfar F, Fereshtehnejad SM, Fijabi DO, Foigt N, Forouzanfar MH, Garcia AC, Geleijnse JM, Gessner BD, Goginashvili K, Gona P, Goto A, Gouda HN, Green MA, Greenwell KF, Gugnani HC, Gupta R, Hamadeh RR, Hammami M, Harb HL, Hay S, Hedayati MT, Hosgood HD, Hoy DG, Idrisov BT, Islami F, Ismayilova S, Jha V, Jiang G, Jonas JB, Juel K, Kabagambe EK, Kazi DS, Kengne AP, Kereselidze M, Khader YS, Khalifa SE, Khang YH, Kim D, Kinfu Y, Kinge JM, Kokubo Y, Kosen S, Defo BK, Kumar GA, Kumar K, Kumar RB, Lai T, Lan Q, Larsson A, Lee JT, Leinsalu M, Lim SS, Lipshultz SE, Logroscino G, Lotufo PA, Lunevicius R, Lyons RA, Ma S, Mahdi AA, Marzan MB, Mashal MT, Mazorodze TT, McGrath JJ, Memish ZA, Mendoza W, Mensah GA, Meretoja A, Miller TR, Mills EJ, Mohammad KA, Mokdad AH, Monasta L, Montico M, Moore AR, Moschandreas J, Msemburi WT, Mueller UO, Muszynska MM, Naghavi M, Naidoo KS, Narayan KM, Nejjari C, Ng M, de Dieu Ngirabega J, Nieuwenhuijsen MJ, Nyakarahuka L, Ohkubo T, Omer SB, Caicedo AJ, Pillay-van Wyk V, Pope D, Pourmalek F, Prabhakaran D, Rahman SU, Rana SM, Reilly RQ, Rojas-Rueda D, Ronfani L, Rushton L, Saeedi MY, Salomon JA, Sampson U, Santos IS, Sawhney M, Schmidt JC, Shakh-Nazarova M, She J, Sheikhbahaei S, Shibuya K, Shin HH, Shishani K, Shiue I, Sigfusdottir ID, Singh JA, Skirbekk V, Sliwa K, Soshnikov SS, Sposato LA, Stathopoulou VK, Stroumpoulis K, Tabb KM, Talongwa RT, Teixeira CM, Terkawi AS, Thomson AJ, Thorne-Lyman AL, Toyoshima H, Dimbuene ZT, Uwaliraye P, Uzun SB, Vasankari TJ, Vasconcelos AM, Vlassov VV, Vollset SE, Waller S, Wan X, Weichenthal S, Weiderpass E, Weintraub RG, Westerman R, Wilkinson JD, Williams HC, Yang YC, Yentur GK, Yip P, Yonemoto N, Younis M, Yu C, Jin KY, El Sayed Zaki M, Zhu S, Vos T, Lopez AD, Murray CJ. Global, regional, and national levels of neonatal, infant, and under-5 mortality during 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet. 2014;384:957-979. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 567] [Cited by in RCA: 535] [Article Influence: 44.6] [Reference Citation Analysis (0)] |
| 6. | Mohamed Ahmed Hamid SM, Ibrahim Shaban KS, Abdulhamid Abdulaziz SB, Ahmed Mohamed SYM, Abdo Osman SK, Abd Alnour Suliman ET. The Impact of Neonatal Sepsis on Long-Term Neurodevelopment: A Systematic Review of Cognitive and Sensory Outcomes. Cureus. 2025;17:e90176. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
| 7. | Dimopoulou V, Glaser K, Giannoni E. Central line-associated blood stream infections in newborns: From vulnerability to prevention. Semin Fetal Neonatal Med. 2025;30:101665. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 2] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 8. | Cho HJ, Cho HK. Central line-associated bloodstream infections in neonates. Korean J Pediatr. 2019;62:79-84. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 12] [Cited by in RCA: 18] [Article Influence: 2.3] [Reference Citation Analysis (0)] |
| 9. | Canadian Nosocomial Infection Surveillance Program1*. Device and surgical procedure-related infections in Canadian acute care hospitals from 2011 to 2020. Can Commun Dis Rep. 2022;48:325-339. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in RCA: 7] [Reference Citation Analysis (0)] |
| 10. | Liu ZR, Bull AL, Phuong LK, Malloy MJ, Friedman ND, Worth LJ. Central- and peripheral-line-associated bloodstream infections in Victorian neonatal intensive care units: findings from a comprehensive Victorian surveillance network, 2008-2024. J Hosp Infect. 2025;161:83-91. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 8] [Reference Citation Analysis (0)] |
| 11. | Rosenthal VD, Desse J, Maurizi DM, Chaparro GJ, Orellano PW, Chediack V, Cabrera R, Golschmid D, Silva CG, Vimercati JC, Stagnaro JP, Perez I, Spadaro ML, Montanini AM, Pedersen D, Paniccia TL, Aguilera AMR, Cermesoni R, Mele JI, Alda E, Paldoro AE, Ortta AR, Cooke B, García MC, Obed MN, Domínguez CV, Saúl PA, Rodríguez Del Valle MC, Bianchi AC, Alvarez G, Pérez R, Oyola C. Impact of the International Nosocomial Infection Control Consortium (INICC)'s Multidimensional Approach on Rates of Central Line-Associated Bloodstream Infection in 14 Intensive Care Units in 11 Hospitals of 5 Cities in Argentina. Infect Control Hosp Epidemiol. 2018;39:445-451. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 8] [Cited by in RCA: 16] [Article Influence: 2.0] [Reference Citation Analysis (0)] |
| 12. | Iyigun I, Aykac K, Basar P, Buyukgullu Z, Durak S, Celik HT, Yigit S, Ozsurekci Y. NICU-specific bundle for minimizing central line-associated bloodstream infections: Comparative health care costs of interventions. Am J Infect Control. 2025;53:1085-1090. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 2] [Cited by in RCA: 1] [Article Influence: 1.0] [Reference Citation Analysis (0)] |
| 13. | Goudie A, Dynan L, Brady PW, Rettiganti M. Attributable cost and length of stay for central line-associated bloodstream infections. Pediatrics. 2014;133:e1525-e1532. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 132] [Cited by in RCA: 168] [Article Influence: 14.0] [Reference Citation Analysis (0)] |
| 14. | Alshahrani KM, Alhuwaishel AZ, Alangari NM, Asiri MA, Al-Shahrani NA, Alasmari AA, Alzahrani OJ, Ayedh AY, Qitmah MM. Clinical Impacts and Risk Factors for Central Line-Associated Bloodstream Infection: A Systematic Review. Cureus. 2023;15:e40954. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 19] [Reference Citation Analysis (0)] |
| 15. | Horbar JD, Carpenter JH, Badger GJ, Kenny MJ, Soll RF, Morrow KA, Buzas JS. Mortality and neonatal morbidity among infants 501 to 1500 grams from 2000 to 2009. Pediatrics. 2012;129:1019-1026. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 399] [Cited by in RCA: 444] [Article Influence: 31.7] [Reference Citation Analysis (0)] |
| 16. | Manzoni P, Kaufman DA, Niklas V, Giuffrè M, Ramelet AS, De Luca D. Expert review of CLABSI prevention in the NICU: supporting the transition of investigational drugs into clinical practice. Eur J Pediatr. 2025;184:492. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 1] [Cited by in RCA: 4] [Article Influence: 4.0] [Reference Citation Analysis (0)] |
| 17. | Al Bizri A, Hanna Wakim R, Obeid A, Daaboul T, Charafeddine L, Mounla N, Nakad P, Yunis K. A Quality improvement initiative to reduce central line-associated bloodstream infections in a neonatal intensive care unit in a low-and-middle-income country. BMJ Open Qual. 2023;12:e002129. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 10] [Reference Citation Analysis (0)] |
| 18. | Johnson J, Akinboyo IC, Curless MS, Milstone AM, Coffin SE. Saving neonatal lives by improving infection prevention in low-resource units: tools are needed. J Glob Health. 2019;9:010319. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 3] [Cited by in RCA: 9] [Article Influence: 1.5] [Reference Citation Analysis (0)] |
| 19. | Balla KC, Rao SP, Arul C, Shashidhar A, Prashantha YN, Nagaraj S, Suresh G. Decreasing Central Line-associated Bloodstream Infections Through Quality Improvement Initiative. Indian Pediatr. 2018;55:753-756. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 15] [Cited by in RCA: 29] [Article Influence: 3.6] [Reference Citation Analysis (0)] |
| 20. | Kaur M, Sophia, Kaur R, Guleria C, Vig S, Angurana SK, Biswal M, Jayshree M. A quality improvement initiative to reduce central line associated blood stream infection in PICU of a tertiary care hospital in North India. Indian J Med Microbiol. 2025;57:100922. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 2] [Reference Citation Analysis (0)] |
| 21. | Fisher D, Cochran KM, Provost LP, Patterson J, Bristol T, Metzguer K, Smith B, Testoni D, McCaffrey MJ. Reducing central line-associated bloodstream infections in North Carolina NICUs. Pediatrics. 2013;132:e1664-e1671. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 73] [Cited by in RCA: 77] [Article Influence: 5.9] [Reference Citation Analysis (0)] |
| 22. | Rosenthal VD, Yin R, Nercelles P, Rivera-Molina SE, Jyoti S, Dongol R, Aguilar-De-Moros D, Tumu N, Alarcon-Rua J, Stagnaro JP, Alkhawaja S, Jimenez-Alvarez LF, Cano-Medina YA, Valderrama-Beltran SL, Henao-Rodas CM, Zuniga-Chavarria MA, El-Kholy A, Agha HM, Sahu S, Anusandhan SO, Bhattacharyya M, Kharbanda M, Poojary A, Nair PK, Myatra SN, Chawla R, Sandhu K, Mehta Y, Rajhans P, Zand F, Abdellatif-Daboor M, Tai CW, Gan CS, Mat Nor MB, Aguirre-Avalos G, Hernandez-Chena BE, Sassoe-Gonzalez A, Villegas-Mota I, Aleman-Bocanegra MC, Bat-Erdene I, Carreazo NY, Castaneda-Sabogal A, Janc J, Belskiy V, Hlinkova S, Yildizdas D, Havan M, Koker A, Sungurtekin H, Dinleyici EC, Guclu E, Tao L, Memish ZA, Jin Z. International Nosocomial Infection Control Consortium (INICC) report of health care associated infections, data summary of 45 countries for 2015 to 2020, adult and pediatric units, device-associated module. Am J Infect Control. 2024;52:1002-1011. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 56] [Cited by in RCA: 52] [Article Influence: 26.0] [Reference Citation Analysis (1)] |
| 23. | Pessoa-Silva CL, Hugonnet S, Pfister R, Touveneau S, Dharan S, Posfay-Barbe K, Pittet D. Reduction of health care associated infection risk in neonates by successful hand hygiene promotion. Pediatrics. 2007;120:e382-e390. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 161] [Cited by in RCA: 138] [Article Influence: 7.3] [Reference Citation Analysis (0)] |
| 24. | Kallimath A, Patnaik SK, Malshe N, Suryawanshi P, Singh P, Gareghat R, Nimbre V, Ranbishe K, Kamble AG, Ambekar V. Quality improvement initiative 'S-A-F-H' to reduce healthcare-associated neonatal sepsis in a tertiary neonatal care unit. BMJ Open Qual. 2024;13:e002336. [RCA] [PubMed] [DOI] [Full Text] [Cited by in RCA: 3] [Reference Citation Analysis (0)] |
| 25. | McLaney E, Morassaei S, Hughes L, Davies R, Campbell M, Di Prospero L. A framework for interprofessional team collaboration in a hospital setting: Advancing team competencies and behaviours. Healthc Manage Forum. 2022;35:112-117. [RCA] [PubMed] [DOI] [Full Text] [Full Text (PDF)] [Cited by in Crossref: 166] [Cited by in RCA: 116] [Article Influence: 29.0] [Reference Citation Analysis (1)] |
| 26. | Petit Dit Dariel O, Cristofalo P. A meta-ethnographic review of interprofessional teamwork in hospitals: what it is and why it doesn't happen more often. J Health Serv Res Policy. 2018;23:272-279. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 28] [Cited by in RCA: 25] [Article Influence: 3.1] [Reference Citation Analysis (0)] |
| 27. | Payne V, Hall M, Prieto J, Johnson M. Care bundles to reduce central line-associated bloodstream infections in the neonatal unit: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2018;103:F422-F429. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 55] [Cited by in RCA: 90] [Article Influence: 11.3] [Reference Citation Analysis (0)] |
| 28. | Humphrey JS. Improving Registered Nurses' Knowledge of Evidence-Based Practice Guidelines to Decrease the Incidence of Central Line-Associated Bloodstream Infections: An Educational Intervention. J Assoc Vasc Access. 2015;20:143-149. [RCA] [DOI] [Full Text] [Cited by in Crossref: 5] [Cited by in RCA: 6] [Article Influence: 0.5] [Reference Citation Analysis (0)] |
| 29. | Thom KA, Li S, Custer M, Preas MA, Rew CD, Cafeo C, Leekha S, Caffo BS, Scalea TM, Lissauer ME. Successful implementation of a unit-based quality nurse to reduce central line-associated bloodstream infections. Am J Infect Control. 2014;42:139-143. [RCA] [PubMed] [DOI] [Full Text] [Cited by in Crossref: 13] [Cited by in RCA: 17] [Article Influence: 1.4] [Reference Citation Analysis (0)] |